IBAVYR 200 MG
RIBAVIRIN : 200 MG · DIN 02439212 · PENDOPHARM DIVISION OF PHARMASCIENCE INC
Health Canada status: DORMANT
What is IBAVYR?
IBAVYR 200 MG contains RIBAVIRIN : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02439212, held by PENDOPHARM DIVISION OF PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 31-Jul-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is IBAVYR used for?
In combination with other agents for the treatment of chronic hepatitis C (CHC) in adults. Not for monotherapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02439212 |
|---|---|
| Brand name | IBAVYR |
| Generic / active ingredient | RIBAVIRIN : 200 MG |
| Manufacturer | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AP01 RIBAVIRIN |
| AHFS class | 38:00.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 31-Jul-2023 |
| Original market date | 2016-04-02 00:00:00 |
How is it administered?
Administered orally in two divided doses with food. Dose varies (800-1200 mg daily) based on weight, genotype, and combination agent. Refer to specific co-administered agent monographs.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly detailed in provided text (standard section 11 mentioned in TOC but content not in snippet).
How is it supplied?
Bottles of 100 tablets.
Contraindications
Hypersensitivity; pregnancy/male partners of pregnant women; hemoglobinopathies (e.g., thalassemia, sickle-cell anemia); coadministration with didanosine.
Warnings and precautions
Not for monotherapy. Hemolytic anemia may worsen cardiac disease; avoid in unstable cardiac disease. Significant teratogenic risk (see Serious Warnings Box).
What can be used instead?
Other Canadian products sharing ATC code J05AP01 RIBAVIRIN. 1 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| VIRAZOLE | 6 G | AEROSOL ; POWDER FOR SOLUTION | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02170140 |
| IBAVYR | 400 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT | DIN 02425890 |
| IBAVYR | 600 MG | TABLET | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT | DIN 02425904 |
| MODERIBA | 200 MG | TABLET | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02436396 |
| MODERIBA | 400 MG | TABLET | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02436418 |
| MODERIBA | 600 MG | TABLET | ABBVIE CORPORATION | CANCELLED POST MARKET | DIN 02436426 |
| VIRAZOLE PWS 6GM/VIAL | 6 G | AEROSOL ; POWDER FOR SOLUTION | VIRATEK INC. | CANCELLED POST MARKET | DIN 00704008 |
Who else supplies RIBAVIRIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. RIBAVIRIN appears in 1325 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.